Nanoparticles News and Research

RSS

New research: 'Good cholesterol' can act as special delivery vehicle for cancer destruction

High-density lipoprotein's hauls excess cholesterol to the liver for disposal, but new research suggests "good cholesterol" can also act as a special delivery vehicle of destruction for cancer.

1 Apr 2011

Mucus may play a key role in penetration of hydrophobic substances into cells

Are our bodies vulnerable to some pollutants whose lack of solubility in water, or "hydrophobicity," has always been thought to protect us from them? New Tel Aviv University research has discovered that this is indeed the case.

31 Mar 2011

Ohio engineers invent new fluorescent nano-particle to tag molecules in biomedical tests

Engineers at Ohio State University have invented a new kind of nano-particle that shines in different colors to tag molecules in biomedical tests.

29 Mar 2011

VisualSonics introduces Vevo LAZR system to advance cancer research

VisualSonics Inc., a leader in real-time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., today announced the launch of the Vevo LAZR Photoacoustics Imaging system for the advancement of cancer research in the pre-clinical imaging market.

25 Mar 2011

Molecular Therapy journal publishes Mirna's new tumor suppressor miRNA mimics data

Mirna Therapeutics, Inc. announced today the publication of new results in the journal Molecular Therapy demonstrating how a neutral lipid emulsion facilitates the systemic delivery of tumor suppressor miRNA mimics and reduces the tumor burden in the lungs of mice.

24 Mar 2011

Contrast agent for tumor diagnostics

X-rays are not the only way: visible and especially infrared light can also be used to image human tissue. The effectiveness of optical imaging processes can be significantly improved with suitable dyes used as contrast agents. In the journal Angewandte Chemie, a team led by Wenbin Lin at the University of North Carolina (Chapel Hill, USA) has now introduced a novel contrast agent that marks tumor cells in vitro. The dye is a phosphorescent ruthenium complex incorporated into nanoparticles of a metal–organic coordination polymer, which allows an extraordinarily high level of dye loading.

23 Mar 2011

Scientists create organic nanoparticle to treat cancer and deliver drugs

A team of scientists from Princess Margaret Hospital have created an organic nanoparticle that is completely non-toxic, biodegradable and nimble in the way it uses light and heat to treat cancer and deliver drugs.

22 Mar 2011

Organic, non-toxic, biodegradable nanoparticle uses light and heat to treat cancer

21 Mar 2011

Scientists create new drug delivery system to treat cancer

Scientists in Syracuse University's Chemistry Department have created a new drug delivery system expected to advance the effectiveness of cancer-killing drugs. It uses gold nanoparticles with attached DNA that binds to a proven anti-cancer drug, Doxorubicin or DOX.

16 Mar 2011

U-M purchases Fluxion's IonFlux system to study nanoscale membrane disruption

Fluxion Biosciences, Inc. announced today that the University of Michigan Department of Chemistry has purchased the IonFlux 16 automated patch clamp instrument.

From Fluxion Biosciences 16 Mar 2011

Anti-cancer drug loaded microcarriers successfully guided to targeted area in the liver

Soon, drug delivery that precisely targets cancerous cells without exposing the healthy surrounding tissue to the medication's toxic effects will no longer be an oncologist's dream but a medical reality, thanks to the work of Professor Sylvain Martel, Director of the Nanorobotics Laboratory at Polytechnique Montr-al.

16 Mar 2011

XTIO2 presents XTI 360 ANTI-GERM SYSTEM to 83rd Academy Award-nominees

XTIO2 INC. (XTI) presented the 83rd Academy® Award-nominees with the XTI ANTI-GERM / ANTI-VOC / ANTI-ALLERGY SYSTEM, consisting of XTI 360™ Nanocoating and XTI™ Nano-Facemask. It is the world's most effective preventive measure and the best defense against germs transmitted via air and contact surfaces.

15 Mar 2011

Nanotechnology might provide greater efficacy of medicines for brain disease

Technology has been developed within Top Institute Pharma that helps medicines be absorbed quicker into the blood and thus be more effective. Researcher Hans de Waard, who is associated with the University of Groningen, will obtain his doctorate on this subject on March 11. De Waard: "Many current medicines are not easily dissolved in the digestive tract, which means that they barely reach the bloodstream.

14 Mar 2011

Oxford Instruments patents to be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction

The Oxford Instruments patents will be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March 31, 2011 in New York City. Oxford Instruments has determined that these patents are not strategic for its ongoing business. The lots include: a concept for the use of magnetic particles for targeted cancer treatment, advanced sterilization techniques, an advanced imaging system, and an advanced microbolometer.

5 Mar 2011

New promising detection technology identifies cancer cells early

Yesterday's Wall Street Journal (March 1) published a lead article on page D1 entitled "Researchers Create Better Ways To Spot Cancer Cells", which described the research by Dr. Edward R. Flynn, of Senior Scientific LLC. The article was authored by Shirley S. Wang.

4 Mar 2011

Nanotechnology holds promise for developing surgical measures

A new review published in WIREs Nanomedicine and Nanobiotechnology explores how nanotechnology may provide powerful new tools that could have a marked impact on the therapeutic and diagnostic measures available to surgeons.

2 Mar 2011

Quebec researchers use Malvern’s new high temperature chromatography system in novel work

Researchers working at NanoQAM, the nanotechnology research centre of the University of Quebec (Montreal, Canada), are successfully innovating novel polymer coatings on the basis of data measured using a Viscotek high temperature gel permeation chromatography (HT-GPC) system from Malvern Panalytical.

From Malvern Panalytical 1 Mar 2011

Nanotechnology holds promise for developing surgical measures

1 Mar 2011

K-State chemistry professor receives Sloan Foundation Fellowship for gold nanoparticle research

A Kansas State University chemistry professor has been selected as a Sloan Research Fellow for her success as a promising young scholar, particularly in the research areas of sustainable energy and gold nanoparticles.

1 Mar 2011

Innovative miniscule gene transport system can cause breast cancer cells to self-destruct

Scientists at Queen's University Belfast have shown that they can deliver a gene directly into breast cancer cells causing them to self-destruct, using an innovative, miniscule gene transport system, according to research published today in the International Journal of Pharmaceutics.

28 Feb 2011

Nanoparticles News and Research

New research: 'Good cholesterol' can act as special delivery vehicle for cancer destruction

Mucus may play a key role in penetration of hydrophobic substances into cells

Ohio engineers invent new fluorescent nano-particle to tag molecules in biomedical tests

VisualSonics introduces Vevo LAZR system to advance cancer research

Molecular Therapy journal publishes Mirna's new tumor suppressor miRNA mimics data

Contrast agent for tumor diagnostics

Scientists create organic nanoparticle to treat cancer and deliver drugs

Organic, non-toxic, biodegradable nanoparticle uses light and heat to treat cancer

Scientists create new drug delivery system to treat cancer

U-M purchases Fluxion's IonFlux system to study nanoscale membrane disruption

Anti-cancer drug loaded microcarriers successfully guided to targeted area in the liver

XTIO2 presents XTI 360 ANTI-GERM SYSTEM to 83rd Academy Award-nominees

Nanotechnology might provide greater efficacy of medicines for brain disease

Oxford Instruments patents to be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction

New promising detection technology identifies cancer cells early

Nanotechnology holds promise for developing surgical measures

Quebec researchers use Malvern’s new high temperature chromatography system in novel work

Nanotechnology holds promise for developing surgical measures

K-State chemistry professor receives Sloan Foundation Fellowship for gold nanoparticle research

Innovative miniscule gene transport system can cause breast cancer cells to self-destruct

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News